These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26272262)

  • 1. Methods for Dissecting Motivation and Related Psychological Processes in Rodents.
    Ward RD
    Curr Top Behav Neurosci; 2016; 27():451-70. PubMed ID: 26272262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motivational Deficits in Schizophrenia and the Representation of Expected Value.
    Waltz JA; Gold JM
    Curr Top Behav Neurosci; 2016; 27():375-410. PubMed ID: 26370946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motivational Deficits and Negative Symptoms in Schizophrenia: Concepts and Assessments.
    Reddy LF; Horan WP; Green MF
    Curr Top Behav Neurosci; 2016; 27():357-73. PubMed ID: 26164592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizophrenia in translation: dissecting motivation in schizophrenia and rodents.
    Simpson EH; Waltz JA; Kellendonk C; Balsam PD
    Schizophr Bull; 2012 Nov; 38(6):1111-7. PubMed ID: 23015686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anhedonia in schizophrenia: Deficits in both motivation and hedonic capacity.
    Wang J; Huang J; Yang XH; Lui SS; Cheung EF; Chan RC
    Schizophr Res; 2015 Oct; 168(1-2):465-74. PubMed ID: 26185892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: a translational link to humans.
    Neill JC; Harte MK; Haddad PM; Lydall ES; Dwyer DM
    Eur Neuropsychopharmacol; 2014 May; 24(5):822-35. PubMed ID: 24287012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of hedonic reaction to reward and incentive motivation in an animal model of the negative symptoms of schizophrenia.
    Ward RD; Simpson EH; Richards VL; Deo G; Taylor K; Glendinning JI; Kandel ER; Balsam PD
    Neuropsychopharmacology; 2012 Jun; 37(7):1699-707. PubMed ID: 22414818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic rescue of motivational deficit in an animal model of the negative symptoms of schizophrenia.
    Simpson EH; Kellendonk C; Ward RD; Richards V; Lipatova O; Fairhurst S; Kandel ER; Balsam PD
    Biol Psychiatry; 2011 May; 69(10):928-35. PubMed ID: 21414604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of motivation on cognitive performance in an animal model of the negative and cognitive symptoms of schizophrenia.
    Ward RD; Winiger V; Higa KK; Kahn JB; Kandel ER; Balsam PD; Simpson EH
    Behav Neurosci; 2015 Jun; 129(3):292-9. PubMed ID: 25914923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral phenotypes for negative symptoms in animal models of schizophrenia.
    Miyamoto Y; Nitta A
    J Pharmacol Sci; 2014; 126(4):310-20. PubMed ID: 25409784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anhedonia, avolition, and anticipatory deficits: assessments in animals with relevance to the negative symptoms of schizophrenia.
    Barnes SA; Der-Avakian A; Markou A
    Eur Neuropsychopharmacol; 2014 May; 24(5):744-58. PubMed ID: 24183826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral approach and avoidance in schizophrenia: an evaluation of motivational profiles.
    Felice Reddy L; Green MF; Rizzo S; Sugar CA; Blanchard JJ; Gur RE; Kring AM; Horan WP
    Schizophr Res; 2014 Oct; 159(1):164-70. PubMed ID: 25153364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome.
    Fervaha G; Foussias G; Agid O; Remington G
    Schizophr Res; 2015 Aug; 166(1-3):9-16. PubMed ID: 25982811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational Assessment of Reward and Motivational Deficits in Psychiatric Disorders.
    Der-Avakian A; Barnes SA; Markou A; Pizzagalli DA
    Curr Top Behav Neurosci; 2016; 28():231-62. PubMed ID: 26873017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically modified mice related to schizophrenia and other psychoses: seeking phenotypic insights into the pathobiology and treatment of negative symptoms.
    O'Tuathaigh CM; Desbonnet L; Waddington JL
    Eur Neuropsychopharmacol; 2014 May; 24(5):800-21. PubMed ID: 24290531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effort-based decision making as an objective paradigm for the assessment of motivational deficits in schizophrenia.
    Fervaha G; Duncan M; Foussias G; Agid O; Faulkner GE; Remington G
    Schizophr Res; 2015 Oct; 168(1-2):483-90. PubMed ID: 26215506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avolition in schizophrenia is associated with reduced willingness to expend effort for reward on a Progressive Ratio task.
    Strauss GP; Whearty KM; Morra LF; Sullivan SK; Ossenfort KL; Frost KH
    Schizophr Res; 2016 Jan; 170(1):198-204. PubMed ID: 26701649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Negative Symptoms Revisited--Toward the Recovery of Persons with Schizophrenia].
    Ikebuchi E
    Seishin Shinkeigaku Zasshi; 2015; 117(3):179-94. PubMed ID: 26524844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinic of apathy in schizophrenia: a critical review of the issue].
    Yazbek H; Raffard S; Del-Monte J; Pupier F; Larue A; Boulenger JP; Gély-Nargeot MC; Capdevielle D
    Encephale; 2014 Jun; 40(3):231-9. PubMed ID: 23958346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCP-induced deficits in murine nest building activity: employment of an ethological rodent behavior to mimic negative-like symptoms of schizophrenia.
    Pedersen CS; Sørensen DB; Parachikova AI; Plath N
    Behav Brain Res; 2014 Oct; 273():63-72. PubMed ID: 25064467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.